Original Research

Published on 24 Mar 2022

Sequential Therapy of Nadroparin and Rivaroxaban in the Initial Treatment of Patients With Acute Pulmonary Embolism

in Respiratory Pharmacology

Wei Xiong
Yunfeng Zhao
Song Liu
He Du
Yanmin Wang
Wenjie Li
Xuejun Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.810455

1,577 views
2 citations

Original Research

Published on 23 Mar 2022

Therapeutic Targeting of Endosome and Mitochondrial Reactive Oxygen Species Protects Mice From Influenza Virus Morbidity

in Respiratory Pharmacology

Eunice E. To
Jonathan R. Erlich
Felicia Liong
Stella Liong
Raymond Luong
Osezua Oseghale
Mark A. Miles
Paris C. Papagianis
Kylie M. Quinn
Steven Bozinovski

Frontiers in Pharmacology

doi 10.3389/fphar.2022.870156

3,096 views
3 citations

Original Research

Published on 23 Mar 2022

Olmesartan Attenuates Single-Lung Ventilation Induced Lung Injury via Regulating Pulmonary Microbiota

in Respiratory Pharmacology

Di Lu
Zhizhi Wang
Zhiming Chen
Jiayang Fan
Jianxue Zhai
Duopei Fang
He Cai
Xiguang Liu
Hua Wu
Kaican Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2022.822615

2,968 views
5 citations

Original Research

Published on 18 Mar 2022

Chemerin Regulates the Proliferation and Migration of Pulmonary Arterial Smooth Muscle Cells via the ERK1/2 Signaling Pathway

in Respiratory Pharmacology

Linqian Peng
Yunwei Chen
Yan Li
Panpan Feng
Yan Zheng
Yongjie Dong
Yunjing Yang
Ruiyu Wang
Ailing Li
Jianghong Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.767705

3,024 views
10 citations

Original Research

Published on 18 Mar 2022

Influenza A Virus-Driven Airway Inflammation may be Dissociated From Limb Muscle Atrophy in Cigarette Smoke-Exposed Mice

in Respiratory Pharmacology

Kevin Mou
Stanley M. H. Chan
Kurt Brassington
Aleksandar Dobric
Simone N. De Luca
Huei Jiunn Seow
Stavros Selemidis
Steven Bozinovski
Ross Vlahos

Frontiers in Pharmacology

doi 10.3389/fphar.2022.859146

2,261 views
1 citation

Original Research

Published on 18 Mar 2022

Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

in Respiratory Pharmacology

Jiang-Shan Tan
Song Hu
Ting-Ting Guo
Lu Hua
Xiao-Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.743210

2,389 views
3 citations

Review

Published on 17 Mar 2022

Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis

in Respiratory Pharmacology

Suh-Young Lee
Chang-Min Lee
Bing Ma
Suchitra Kamle
Jack A. Elias
Yang Zhou
Chun Geun Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2022.826471

6,985 views
11 citations

Original Research

Published on 17 Mar 2022

Number 2 Feibi Recipe Inhibits H2O2-Mediated Oxidative Stress Damage of Alveolar Epithelial Cells by Regulating the Balance of Mitophagy/Apoptosis

in Respiratory Pharmacology

Xiaofeng Gu
Qi Long
Wan Wei
Jiahuan Tong
Zhipeng Li
Zhengju Zhang
Yang Jiao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.830554

3,429 views
10 citations

Original Research

Published on 14 Mar 2022

Mitochondrial Protein Akap1 Deletion Exacerbates Endoplasmic Reticulum Stress in Mice Exposed to Hyperoxia

in Respiratory Pharmacology

Sahebgowda Sidramagowda Patil
Ramani Soundararajan
Jutaro Fukumoto
Mason Breitzig
Helena Hernández-Cuervo
Matthew Alleyn
Muling Lin
Venkata Ramireddy Narala
Richard Lockey
Narasaiah Kolliputi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.762840

2,757 views
5 citations

Original Research

Published on 14 Mar 2022

Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway

in Respiratory Pharmacology

Zhen Li
Jing Geng
Bingbing Xie
Jiarui He
Jing Wang
Liang Peng
Yinan Hu
Huaping Dai
Chen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.834604

3,739 views
8 citations

Review

Published on 10 Mar 2022

Omalizumab and IgE in the Control of Severe Allergic Asthma

in Respiratory Pharmacology

Yasuhiro Gon
Shuichiro Maruoka
Kenji Mizumura

Frontiers in Pharmacology

doi 10.3389/fphar.2022.839011

10,647 views
18 citations

Mini Review

Published on 10 Mar 2022

Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis

in Respiratory Pharmacology

Yasuhiko Koga
Haruka Aoki-Saito
Yosuke Kamide
Makiko Sato
Hiroaki Tsurumaki
Masakiyo Yatomi
Tamotsu Ishizuka
Takeshi Hisada

Frontiers in Pharmacology

doi 10.3389/fphar.2022.865318

6,498 views
19 citations

Original Research

Published on 09 Mar 2022

Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway

in Respiratory Pharmacology

Xingxing Hu
Menglin Zou
Lan Ni
Mingyang Zhang
Weishuai Zheng
Bing Liu
Zhenshun Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.829673

6,475 views
16 citations

Original Research

Published on 09 Mar 2022

ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation

in Respiratory Pharmacology

Dongxin Chen
Huirong Tang
Hongchao Jiang
Lei Sun
Wenjuan Zhao
Feng Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2022.835979

4,227 views
9 citations

Review

Published on 08 Mar 2022

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets

in Respiratory Pharmacology

Corrado Pelaia
Enrico Heffler
Claudia Crimi
Angelantonio Maglio
Alessandro Vatrella
Girolamo Pelaia
Giorgio Walter Canonica

Frontiers in Pharmacology

doi 10.3389/fphar.2022.851940

12,833 views
67 citations

Review

Published on 04 Mar 2022

Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review

in Respiratory Pharmacology

Laura Bergantini
Alessandro Mainardi
Miriana d’Alessandro
Paolo Cameli
David Bennett
Elena Bargagli
Piersante Sestini

Frontiers in Pharmacology

doi 10.3389/fphar.2022.748931

5,176 views
29 citations

Navigation group

Articles

Sequential Therapy of Nadroparin and Rivaroxaban in the Initial Treatment of Patients With Acute Pulmonary Embolism

Therapeutic Targeting of Endosome and Mitochondrial Reactive Oxygen Species Protects Mice From Influenza Virus Morbidity

Olmesartan Attenuates Single-Lung Ventilation Induced Lung Injury via Regulating Pulmonary Microbiota

Chemerin Regulates the Proliferation and Migration of Pulmonary Arterial Smooth Muscle Cells via the ERK1/2 Signaling Pathway

Influenza A Virus-Driven Airway Inflammation may be Dissociated From Limb Muscle Atrophy in Cigarette Smoke-Exposed Mice

Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis

Number 2 Feibi Recipe Inhibits H2O2-Mediated Oxidative Stress Damage of Alveolar Epithelial Cells by Regulating the Balance of Mitophagy/Apoptosis

Mitochondrial Protein Akap1 Deletion Exacerbates Endoplasmic Reticulum Stress in Mice Exposed to Hyperoxia

Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway

Omalizumab and IgE in the Control of Severe Allergic Asthma

Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis

Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway

ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets

Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review